Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen

Inclusion Criteria: * Type 1 or type 2 diabetic patients * Performing auto-glycaemic control (at least 2 glycemias a day) * Treated with insulin by a basal-bolus regimen for at least 1 year and using the same method of administration for at least 3 months (insulin pen or pump) * Who have an Apple® or Androïde® Smartphone compatible, or intend to acquire one before their participation in the study * Whose HbA1c dating of less 1 month and more than 3 months is ≥ 8% * Who are able to understand and follow the study protocol * Who have given their signed consent to take part in the study * Subject affiliated to the French National Health Insurance funds or benefiting from such insurance Exclusion Criteria: * Age \< 18 years old * Patients who have used the DIABEO system within 6 months before inclusion * Participation in a clinical study within 6 months, except for the Meos (or télédiab 3) study after a participation period of 6 months * Patients who are pregnant or who wish to become pregnant during the study. * Patients treated with human insulin A patient pre-screening register will be set up in each centre to establish the reasons for DM1/DM2 patients treated with a basal-bolus insulin regimen who are not taking part in the study.